Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Adrenal cancer in 2013

Time to individualize treatment for adrenocortical cancer?

Nature Reviews Endocrinology volume 10, pages 76–78 (2014)Cite this article

Subjects

2013 was a good year for adrenocortical cancer, as the new knowledge gained holds great promise for patients. Advances were made in genetics, epigenetics, the advent of related technological and bioinformatic tools, and the feasibility of massive screening of people and samples.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Hyperplasia–adenoma–carcinoma sequence and molecular heterogeneity in adrenocortical cancer.

References

  1. Ribeiro, R. C. et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl Acad. Sci. USA 98, 9330–9335 (2001).

    Article  CAS  Google Scholar 

  2. Fassnacht, M. et al. Combination chemotherapy in advanced adrenocortical carcinoma. N. Engl. J. Med. 366, 2189–2197 (2012).

    Article  CAS  Google Scholar 

  3. Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333–339 (2013).

    Article  CAS  Google Scholar 

  4. Stratakis, C. A. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony. Trends Endocrinol. Metab. 14, 404–410 (2003).

    Article  CAS  Google Scholar 

  5. Marjanovic, N. D., Weinberg, R. A. & Chaffer, C. L. Cell plasticity and heterogeneity in cancer. Clin. Chem. 59, 168–179 (2013).

    Article  CAS  Google Scholar 

  6. Drelon, C., Berthon, A. & Val, P. Adrenocortical cancer and IGF2: is the game over or our experimental models limited? J. Clin. Endocrinol. Metab. 98, 505–507 (2013).

    Article  CAS  Google Scholar 

  7. Custódio, G. et al. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J. Clin. Oncol. 31, 2619–2626 (2013).

    Article  Google Scholar 

  8. Ronchi, C. L. et al. Single nucleotide polymorphism array profiling of adrenocortical tumors - evidence for an adenoma carcinoma sequence? PLoS ONE 8, e73959 (2013).

    Article  CAS  Google Scholar 

  9. Gaujoux, S. et al. Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R. PLoS ONE 8, e55743 (2013).

    Article  CAS  Google Scholar 

  10. De Martino, M. C. et al. Molecular screening for a personalized treatment approach in advanced adrenocortical cancer. J. Clin. Endocrinol. Metab. 98, 4080–4088 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author's work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD).

Author information

Authors and Affiliations

  1. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), CRC Room 1-3330, East Laboratories, Building 10-CRC, 10 Center Drive, SEGEN/PDEGEN, NICHD, NIH, Bethesda, 20892, MD, USA

    Constantine A. Stratakis

Authors
  1. Constantine A. Stratakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Constantine A. Stratakis.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stratakis, C. Time to individualize treatment for adrenocortical cancer?. Nat Rev Endocrinol 10, 76–78 (2014). https://doi.org/10.1038/nrendo.2013.263

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2013.263

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer